Sodium Acetate Anhydrous Solution, Concentrate
NDC Package 70069-047-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Sodium Acetate Anhydrous solution is sodium acetate injection (2 mEq/mL) is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. This formulation utilizes a solution, concentrate delivery system. Marketed by Somerset Therapeutics, Llc, this product is identified by NDC 70069-047 and is authorized under FDA application ANDA219826.

Identification & Billing

NDC Package Code
70069-047-25
Package Description
25 VIAL, GLASS in 1 CARTON / 50 mL in 1 VIAL, GLASS
Product Code
11-Digit Billing Format
70069004725
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sodium Acetate Anhydrous
Non-Proprietary Name
Sodium Acetate Anhydrous
Substance Name
Sodium Acetate Anhydrous
Dosage Form
Solution, Concentrate - A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its nonactive parts.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
Sodium acetate injection (2 mEq/mL) is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.

Regulatory & Marketing

Labeler Name
Somerset Therapeutics, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA219826
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-23-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70069-047-25 identifies a specific commercial package of 25 vial, glass in 1 carton / 50 ml in 1 vial, glass of Sodium Acetate Anhydrous, a human prescription drug labeled by Somerset Therapeutics, Llc. This solution, concentrate is formulated for intravenous use and contains sodium acetate anhydrous as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Somerset Therapeutics, Llc on October 23, 2025. The current certification is valid through December 31, 2026.

How is this Somerset Therapeutics, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70069004725. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70069-047-25
11-Digit CMS (5-4-2)
70069-0047-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.